Sekisui Invests $1.9m in New Bioprocess Innovation Centre in the UK

Products
- Clinical Chemistry
  - - Clinical Chemistry Reagents
      View All
    - SEKURE® Clinical Chemistry Kits
      View all
    - Calibrators, Controls, & Linearity
      View All
  - - Diabetes Meter
      Learn More
    - Product Documentation
      View All
- Enzymes
  - - Clinical Chemistry Enzymes
      View All
    - Pharmaceutical Antibiotic Production
      View All
    - Biosensors
      View All
  - - Molecular Enzymes
      View All
    - Immunodiagnostics
      View All
  - - Product Documentation
      View All
- Point-of-Care Testing
  - - Rapid Tests
      - OSOM®
      View All
    - Molecular
      - Metrix®
      View All
    - Diagnostic Reader
      - Acucy®
      View All
  - - Patient Solutions
      - Women’s Health
      - Respiratory Health
      View All
  - - Product Documentation
      View All
- Home Testing
  - - OSOM® Home Tests
      - OSOM® COVID-19 Antigen Home Test
      - OSOM® Flu SARS-CoV-2 Combo Test
      View All
- Pre-Analytic Systems
  - - Pre-Analytic Systems
      View All
  - - Product Documentation
      View All
- Biopharma Services
  - - Biopharma Services
      Learn More
  - - Product Documentation
      View All
Support & Resources
- Group
  - - Support
      View All
  - - Product Documents
      - Safety Data Sheets
      View All
  - - Resources
      View All
Solutions
- Column
  - - For Core Laboratories
      Learn More
  - - For Healthcare Professionals
      Learn More
  - - For Manufacturers
      Learn More
  - - For Distributors
      Learn More
About Us
- Group
  - - About Sekisui Diagnostics
      Learn More
  - - News
      View All
    - Events
      View All
  - - Leadership
      Meet the Team
Insights
Careers
- Column
  - - Job Openings
      View All
  - - Culture
      Learn More

Headquartered in Burlington, MA, US, Sekisui is planning future investment in expanding cGMP manufacturing capabilities.